KURA
NASDAQ · Biotechnology
Kura Oncology Inc
$9.56
+0.27 (+2.91%)
Open$9.35
Previous Close$9.29
Day High$9.61
Day Low$9.27
52W High$12.49
52W Low$5.45
Volume—
Avg Volume1.03M
Market Cap837.03M
P/E Ratio—
EPS$-3.18
SectorBiotechnology
Analyst Ratings
Strong Buy
22 analysts
Price Target
+380.3% upside
Current
$9.56
$9.56
Target
$45.92
$45.92
$25.11
$45.92 avg
$52.51
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 67.39M | 146.41M | 142.51M |
| Net Income | -278,286,973 | 21.31M | 25.50M |
| Profit Margin | -413.0% | 14.6% | 17.9% |
| EBITDA | -302,180,918 | 41.90M | 41.44M |
| Free Cash Flow | — | 24.20M | 22.28M |
| Rev Growth | — | -6.0% | +22.0% |
| Debt/Equity | 0.06 | 0.38 | 0.34 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |